Crystal Crop Protection IPO
Open Date
18 Nov 2026
Close Date
20 Nov 2026
Open Date
18 Nov 2026
Close Date
20 Nov 2026
Min Investment
Lot Size
Issue Size
Price Range
Subscribed
This IPO is Open for Pre Apply.
No Subcription Details for this IPO
IPO subscription details, if any,
will appear here

Founded In
1994
CEO
Anil Nirwal
Financials of Crystal Crop Protection IPO
| Key Performance Indicators | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Operating Revenue | 2,690.51 | 3,151.97 | 1,197.15 |
| Other Income | 41.43 | 29.01 | 12.06 |
Total Income | 2,731.94 | 3,180.98 | 1,209.21 |
Total Expenses | 2,564.33 | 2,983.25 | 1,026.81 |
| Profit Before Tax | 167.41 | 193.39 | 182.30 |
Total Profit | 118.39 | 144.91 | 135.78 |
All figures are in crores (₹)

Utilisation of Proceeds
All figures are in crores (₹)
| Purpose | Amount |
|---|---|
| The company intends to utilize a portion of the Net Proceeds towards full or partial repayment/prepayment of certain outstanding borrowings availed from banks and financial institutions, including payment of any pre-payment penalties and accrued interest, to reduce indebtedness and maintain a favorable debt-equity ratio. | 248 |
| The company proposes to invest in its wholly-owned material subsidiary, Saffire Crop Science Private Limited, to enable repayment/pre-payment, in full or in part, of all or a portion of certain outstanding borrowings of the subsidiary, including pre-payment penalties and accrued interest. | 22 |
| The company intends to utilize a portion of the Net Proceeds and Pre-IPO Proceeds towards funding inorganic growth through unidentified acquisitions and strategic initiatives, subject to the cumulative amount not exceeding a specified percentage of the Gross Proceeds. | - |
| The company intends to deploy the balance of Net Proceeds and Pre-IPO Proceeds towards general corporate purposes including funding growth opportunities, business development initiatives, meeting ongoing contingencies, and employee expenses, subject to the amount not exceeding a specified percentage of Gross Proceeds. | - |

- Strong R&D Capabilities Backed by Advanced Technology Infrastructure and Collaborations: The company operates a fully integrated R&D model with an in-house GLP-approved KRDC facility, 28 patents filed globally (18 granted in India), 14 commercialized as of March 31, 2026, and an innovation rate of 30.27% in Crystal Crop Protection branded formulation business for Q1 FY2027.
- A Deep Connect with Indian Farmers Resulting in Strong Brand Equity: The company has built strong brand equity through iconic acquired brands (e.g., Gramoxone, Bavistin, Proclaim) and in-house brands; Bavistin recorded 100% awareness among surveyed grape farmers, and Amora reached 85% awareness, expanding to ~12 lakh acres of soybean farming.
- Operational Excellence with Focus on Multi-Pronged Go-to-Market Strategy: The company maintains a pan-India distribution network of 14,717 independent distributors across 23 states and 4 union territories, supported by 729 crop protection and 489 seeds sales executives, and a two-brand architecture (Crystal and Saffire) with non-overlapping channels.
- Vertically Integrated Manufacturing Operations Backed by Robust R&D and Strong Supply Chain: The company operates 4 formulation units (aggregate capacity 75,962 MT) and 2 technical units (aggregate capacity 4,717 MT), with historical capex investments of ₹2,896.57 million, and a 'Make or Import' flexibility supported by backward integration into intermediates.
- Strategic Acquisitions and Successful Integration of Growth Opportunities: The company has completed 8 crop protection and 5 seed acquisitions, integrating brands such as Bavistin (revenue scaled from ₹544.59 million to ₹938.67 million post-acquisition) and Proclaim/Tilt/Blue Copper (scaled to ₹2,005.99 million in Fiscal 2026).
- Diversification Across Business Verticals, Geographies, Product Categories and Crops: The company's revenue is diversified across crop protection (₹24,765.65 million) and seeds (₹5,851.87 million) in Fiscal 2026, spanning domestic branded, domestic corporate, and international segments across 23 states, 4 union territories, and 14 overseas jurisdictions.
- Multi-Generational Leadership Supported by Qualified and Experienced Management and Marquee Investor: The company benefits from promoters with cumulatively over 50 years of agrochemical industry experience, a Harvard-trained Chairman & MD, a senior management team with diverse sectoral expertise, and backing from marquee investor International Finance Corporation (IFC).

